Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 7 - Jul 12
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
Corid (Amprolium) 1.25% Pellets 10lbCorid (Amprolium) 1. 25% Pellets, Type C Medicated for Calves, 10lb Aids in the prevention and treatment of coccidiosis caused by Eimeria bovis and E. zuernii in calves. Dosage: For 21 day prevention 1 lb per 2,500 lbs body wt daily for 21 days. Top dress or mix daily with feed ration. Provides 227 mg amprolium per 100 lbs body weight. Feed during periods of exposure or when experience indicates coccidiosis is likely to be a hazard. Dosage: For 5 day
Corid (Amprolium) 1.25% Pellets, Type C Medicated for Calves, 10lb
Aids in the prevention and treatment of coccidiosis caused by Eimeria bovis and E. zuernii in calves.
Dosage: For 21-day prevention - 1 lb per 2,500 lbs body wt daily for 21 days. Top-dress or mix daily with feed ration.
Provides 227 mg amprolium per 100 lbs body weight. Feed during periods of exposure or when experience indicates coccidiosis is likely to be a hazard.
Dosage: For 5-day treatment - 2 lbs per 2,500 lbs body weight daily for 5 days.
Provides 454 mg amprolium per 100 lbs body weight. Use on a herd basis only; when one or more calves show signs of coccidiosis, it is likely that the rest of the group has been exposed, and all calves in group should be treated.
24 hr slaughter withdrawal. A withdrawal period has not been established in pre-ruminating calves. Not for use in veal calves.
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.2 ★★★★★
Based on 427 reviews
Sort
Product Reviews
★★★★★ 4
good start
Format: Kindle
Good start been a while since we see Peter do a mystery investigation hopefully Peter can keep this job. Love the art by Pepe Larraz hopefully he sticks around for a long time
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 9, 2025
★★★★★ 5
Really good!
Format: Kindle
Great comic! Good continuation of the series before and art style is really good! Gives you a good view into the struggle of Peter As he tries to actually live life with being Spider-Man as well
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 13, 2025
★★★★★ 5
Amazing!
Format: Kindle
Really good start! I am liking this series a lot. Will be here for future issues! Read it today! Its very good.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 11, 2025
★★★★★ 5
Very good
Format: Kindle
So good my favorite series of 2025! Can't wait to read more. Better not being with MJ is different but shay is pretty cool.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on June 17, 2025
★★★★★ 2
An immature take on Peter Parker only suitable for the most immature reader
Format: Kindle
Someday, Marvel Comics won't be controlled by white male Boomers/GenXers who make Peter Pan look well adjusted and who incessantly try to recapture a childhood that never actually existed while believing women have cooties and adult relationships are icky. But until then, we get Amazing Spider-Man by Joe Kelly, whose writing is the living embodiment of the Steve Buscemi "How do you do, my fellow kids" meme.
This run is boring, trite and cliched. You could probably get a more insightful and original story by asking ChatGPT to write one for you. The only thing going for the run - so far - is that Kelly at least isn't outright aggressively antagonizing the reader unlike the previous writer. It's just...bland and mediocre.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on December 21, 2025